Eppen_SPLASH_June2020
Msc_Jun22 Advertisement
  Editorial
 AN AMBITIOUS TARGET TO END AIDS   
 Wednesday, June 22, 2022 
 Governments of over 190 nations, including India, have pledged to end AIDS by 2030 by adopting the UN Sustainable Development Goals. 
  Past Editorial...  
Merck_NextGen_PB_Jun2022
TODAY'S NEWS
12:00  [IST]US FDA places clinical hold on Astellas’ FORTIS trial of AT845 in adults with late-onset pompe disease
11:00  [IST]Ipsen to acquire biopharmaceutical company, Epizyme
10:00  [IST]New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta had no evidence of disease activity
09:00  [IST]EU CHMP recommends approval of Lynparza as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer
more news >>
TOP NEWS
08:00  [IST]PCI expects security deposit from institutions to act as safety net for students and teachers
08:00  [IST]AKCDA appeals to traders to boycott corporate entities in medical business
08:00  [IST]Industry eyes 3D printing for manufacture as the future to spur easy fabrication of tablets with multiple APIs
08:00  [IST]Clirnet targets to grow doctor base to 300,000+ by year end
08:00  [IST]Dermatology sector set to boom in the post Covid-19 market
08:00  [IST]High input costs continue taking a toll on drug manufacturers
more news >>
6Sugar_Free_Sweetener.gif
YESTERDAY'S NEWS
18:00  [IST]Teva presents positive interim results from PEARL study of Ajoy in patients with chronic migraine or episodic migraine at EAN congress
17:00  [IST]Researchers find oral antiviral drug that could provide an effective treatment against respiratory syncytial virus
16:00  [IST]WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics
15:00  [IST]Harrow Health introduces Iopidine 1% and Maxitrol in US markets
14:30  [IST]US FDA accepts Emergent BioSolutions’ BLA for AV7909 anthrax vaccine candidate
14:00  [IST]Intellia, Regeneron announce positive interim data from phase 1 study of CRISPR-based NTLA-2001 to treat transthyretin amyloidosis
more news >>
INTERVIEW  
Pharmexcil to explore export promotion opportunities for pharma exporters by holding B2B and BSM meets
S_V_Veerramani.jpgS V Veeramani, president of Indian Drug Manufacturers’ Association (IDMA)
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the new D Pharm syllabus published by PCI adequate to create next-gen pharmacists?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
truking"
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |